(Reuters) - U.S. stocks opened flat on Friday on nerves over a record rise in coronavirus cases nationwide hurting Corporate America, while data indicating Gilead (NASDAQ:GILD)'s antiviral drug showed improved clinical recovery in COVID-19 patients kept losses in check.
The Dow Jones Industrial Average (DJI) fell 15.74 points, or 0.06%, at the open to 25,690.35. The S&P 500 (SPX) opened higher by 0.42 points, or just 0.01%, at 3,152.47. The Nasdaq Composite (IXIC) dropped 1.84 points, or 0.02%, to 10,545.91 at the opening bell.